Moldova Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Moldova Pharmaceuticals and Healthcare Report

Moldova Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Moldova Pharmaceuticals and Healthcare Report
Published Sep 10, 2016
72 pages — Published Sep 10, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Encouraging prescription by International Non-proprietary Names (INNs) rather than brands. Unresolved political issues, corruption and cumbersome bureaucracy to continue to deter foreign investment. ...Demographic imbalance poses long-term challenges to financing care and provision. Pharmaceutical market is extremely sensitive to consumer purchasing power, which in turn is highly vulnerable to economic shocks. Demographic imbalance poses long-term challenges to financing care and provision. Geo-political tension between Russia and neighbouring countries threatens to disrupt trade flows.

...Political uncertainty persists in Moldova, despite the appointment of a new Prime Minister in January ----. Allegations of corruption against the pro-EU ruling party have persisted since the November ---- corruption scandal, and there have been recurrent widespread protests since then. ...Political uncertainty persists in Moldova, despite the appointment of a new Prime Minister in January ----. Allegations of corruption against the pro-EU ruling party have persisted since the November ---- corruption scandal, and there have been recurrent widespread protests since then. Moldova will also hold direct elections for the presidency on October -- ----. Although the presidency is ceremonial, it carries considerable prestige. The election is likely to be a battle between a pro-EU and pro-Russian candidate, reflecting an ongoing geopolitical struggle in Moldova.

...The economy has returned to mild economic growth, driven mainly by an increase in private consumption, although growth will remain subdued in ----. Credit conditions will see a slow recovery due the recent IMF program and remittances will improve in the wake of Russia s ongoing recovery. ...The economy has returned to mild economic growth, driven mainly by an increase in private consumption, although growth will remain subdued in ----. Credit conditions will see a slow recovery due the recent IMF program and remittances will improve in the wake of Russia s ongoing recovery. However, the banking sector remains weak and ongoing political uncertainty will limit the recovery in household spending. ...

  
Source:
Document ID
2040-4085
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Moldova Pharmaceuticals and Healthcare Report" Sep 10, 2016. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Moldova-Pharmaceuticals-and-Healthcare-Report-2026-748>
  
APA:
Business Monitor International - Industry Reports. (2016). Moldova Pharmaceuticals and Healthcare Report Sep 10, 2016. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Moldova-Pharmaceuticals-and-Healthcare-Report-2026-748>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.